Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Panacea Biotec Ltd - 531349 - Notice Of Extraordinary General Meeting ('EGM') Of The Company And Details Of Cut-Off Date For E-Voting And E-Voting Period

 We would like to inform you that an EGM of the Company is scheduled to be held on Monday, March 25, 2019 at 11:30 A.M. at the Registered Office of the Company at Ambala-Chandigarh Highway, Lalru - 140501, Punjab. Further, pursuant to the provisions of Section 108 of the Act read with Rule 20 of the Companies (Management and Administration) Rules, 2014, as amended from time to time and Regulation 44 of the SEBI LODR Regulations, 2015, the Company is pleased to provide remote e-voting facility to its members to cast their votes electronically on all resolutions set forth in enclosed Notice. Further, relating to the EGM of the Company, you are requested to take on record the following: 1.For the purpose of exercising remote e-voting facility, the cut-off date shall be Monday, March 18, 2019. 2.The remote e-voting period shall commence on Friday, March 22, 2019 (from 09:00 a.m. IST) and end on Sunday, March 24, 2019 (upto 05:00 p.m. IST). This is for your kind information and record please
02-03-2019
Bigul

Panacea Biotec Ltd - 531349 - Disclosure Under Regulation 30(2) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 In continuation to our earlier communication dated February 26, 2019 intimating about the outcome of the Board Meeting of the Company held on February 26, 2019, please find enclosed herewith the detailed annexures as required under Regulation 30(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
27-02-2019
Bigul

Panacea to raise 864 crore for one-time payment to lenders

 Panacea Biotec on Tuesday said its board has approved raising up to 864 crore for one-time settlement with its lenders and other purposes.The company
26-02-2019
Bigul

PANACEA BIOTEC LTD. - 531349 - Outcome of Board Meeting

 Pursuant to Reg. 30 of SEBI Listing Regulations, 2015, we would like to inform you that the Board of the Company has, at its meeting held today, inter-alia, considered and approved the following:- 1. One time settlement with the consortium of lenders of the Company. 2. Raising of funds through issue of Listed/Unlisted, Secured/Unsecured Redeemable Non-Convertible Debentures, aggregating upto Rs.864 Crore 3. Demerger of real estate business of the Company through Scheme of Arrangement (with few modifications in the Scheme of Arrangement which was earlier approved by the Board on 13.09.2017) subject to applicable approvals. 4. Notice of EGM of the Company, inter-alia, covering: a. Raising of funds through issue of warrants by issuing up to 71,11,111 warrants of Rs.180 each, exercisable into equal number of Equity Shares of face value of Re.1/- each of the Company on a preferential basis amounting upto Rs.128 Crore; and 5. Transfer of the pharmaceutical formulations business of the Company to a wholly owned subsidiary of the Company (to be incorporated), as a going concern. The meeting of the Board commenced at 11:30 A.M. and concluded at 05:00 P.M.
26-02-2019
Bigul

PANACEA BIOTEC LTD. - 531349 - Closure of Trading Window

 Pursuant to the Code of Conduct of the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window of the Company shall remain closed for all Designated Persons including Promoters, Directors, Key Managerial Personnel and Designated Employees of the Company from February 22, 2019 to February 28, 2019 (both days inclusive).
21-02-2019
Bigul

Panacea Biotec Ltd - 531349 - Board Meeting Intimation for Considering Proposal Of Funds Raising

 PANACEA BIOTEC LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/02/2019 ,inter alia, to consider and approve raising of funds
21-02-2019
Bigul

Panacea Biotec Ltd - 531349 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Compliance under Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 In continuation to our letter dated February 14, 2019 for approving the Un-Audited Financial Results (Provisional) for the quarter and nine months ended December 31, 2018 and pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith newspaper copies of Extract of Statement of Un-Audited Financial Results for the quarter and nine months ended December 31, 2018, published in the following newspapers on February 15, 2019:- Business Standard (English); Desh Sewak (Punjabi)
15-02-2019
Bigul

PANACEA BIOTEC LTD. - 531349 - Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter And Nine Months Ended December 31, 2018

 In continuation to our letter dated 05.02.2019 and pursuant to Regulations 30 and 33 of SEBI LODR Regulations, 2015, we would like to inform you that the Board of Directors of the Company has, at its meeting held today, i.e. 14.02.2019, inter-alia, considered and approved the Unaudited Financial Results (Provisional) of the Company (which have been subjected to Limited Review by the Statutory Auditors) for the quarter and nine months ended 31.12.2018. The same were also reviewed by the Audit Committee in its meeting held on 14.02.2019. Further, pursuant to Regulation 46(2)(l) of SEBI LODR Regulations, the abovesaid financial results are being uploaded on the website of the Company i.e. www.panacea-biotec.com. The meeting of the Board of Directors commenced at 11:30 A.M. and concluded at 04:00 P.M.
14-02-2019
Bigul

Panacea Biotec Ltd - 531349 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Compliance under Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 In continuation to our letter dated February 05, 2019 intimating the date of proposed Board Meeting scheduled to be held on February 14,2019, for approving the Unaudited Financial Results(Provisional) for the quarter and nine months ended 31st December, 2018 and pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith newspaper copies of the notice of Board Meeting published in the following newspapers on February 06, 2019:- Business Standard (English); Desh Sewak (Punjabi)
06-02-2019
Bigul

Panacea Biotec Ltd - 531349 - Closure of Trading Window

 Pursuant to the Code of Conduct of the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window of the Company shall remain closed for all designated persons including promoters, directors, key managerial personnel and designated employees of the Company from 6th February, 2019 to 16th February, 2019 (both days inclusive).
05-02-2019
Next Page
Close

Let's Open Free Demat Account